RxSight (RXST) Inventory (2020 - 2026)

RxSight's Inventory history runs 7 years deep, the most recent figure standing at $36.7 million for Q1 2026.

• Quarterly Inventory rose 51.79% year-over-year to $36.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $36.7 million (up 51.79% YoY) and the FY2025 annual result came in at $33.5 million, up 48.22% from the prior year.
• Inventory was $36.7 million for Q1 2026 at RxSight, up from $33.5 million in the prior quarter.
• Across five years, Inventory topped out at $36.7 million in Q1 2026 and bottomed at $8.5 million in Q1 2022.
• A 5-year average of $21.1 million and a median of $18.9 million in 2023 frame the typical range for Inventory.
• Annual changes were most pronounced in 2023 — Inventory surged 117.5% — and 2024, when it advanced 1.27%.
• RxSight's Inventory stood at $14.8 million in 2022, then increased by 17.43% to $17.4 million in 2023, then gained by 29.85% to $22.6 million in 2024, then surged by 48.22% to $33.5 million in 2025, then increased by 9.34% to $36.7 million in 2026.
• Business Quant data shows RXST's Inventory at $36.7 million in Q1 2026, $33.5 million in Q4 2025, and $30.4 million in Q3 2025.